Birth Control News and Research

RSS

Demand for long-acting reversible contraception seems to be on rise

Not long after Donald Trump was elected president, descriptive reports began rolling in: Demand for long-acting, reversible contraception such as intrauterine devices and implants seemed to be on the rise.

4 Feb 2019

For California attorney general Xavier Becerra, resistance is personal

When President Donald Trump demands a border wall or threatens to deport young unauthorized immigrants, one of the loudest opposition voices comes from the son of Mexican immigrants — who also happens to be California's top lawyer.

4 Feb 2019

Warmer water and chemical exposure influence gene expression in North American fish

Warmer water temperatures, combined with low-level exposure to chemicals already known to be harmful to aquatic life, influence the expression of genes in the offspring of an abundant North American fish species - and threaten organisms whose sex determination is sensitive to water temperature.

1 Feb 2019

Buffalo researchers receive grant to quicken development of generic equivalents of contraceptives

University at Buffalo researchers received an $880,000 grant to help quicken the development of generic equivalents of contraceptives and other drugs delivered vaginally or to the uterus, such as by intrauterine devices

21 Jan 2019

Contraceptive patch that could provide 6 months of contraception within seconds

Most birth control methods involving hormones involve daily intake of pills. Long acting contraceptive methods that involve implants or intrauterine devices (IUDs) need regular visits to the doctor and are not as acceptable to many women.

15 Jan 2019

Protein discovery could lead to mosquito "birth control"

Researchers have discovered a way of preventing mosquito eggs from hatching, paving the way for drugs that could serve as “birth control” within mosquito populations.

9 Jan 2019

Women’s intentions and attitude matter when it comes to using contraception

A new Veterans Affairs study adds to the evidence that women's intentions around becoming pregnant don't fully explain whether and how they use contraception. Rather, their attitudes toward becoming pregnant also play a role.

30 Nov 2018

Sexuality education before age 18 may reduce risk of sexual assault in college

Students who receive sexuality education, including refusal skills training, before college matriculation are at lower risk of experiencing sexual assault during college, according to new research published today in PLOS ONE.

16 Nov 2018

Study: Lesbian women less likely to report receiving birth control prescription or counseling

According to a new study that used data from the National Survey of Family Growth 2006-2015, lesbian women were less likely to report receiving a birth control prescription or birth control counseling compared with heterosexual women.

7 Nov 2018

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva® in people with previously untreated chronic lymphocytic leukemia and co-existing medical conditions, met its primary endpoint and showed a statistically significant reduction in the risk of disease worsening or death compared to standard-of-care Gazyva plus chlorambucil.

1 Nov 2018

Baby's tears make female mice to reject male sexual advances

A substance in young mice's tears makes female mice more likely to reject male sexual advances. This research is part of ongoing efforts at the University of Tokyo to understand how animals communicate using chemicals called pheromones.

26 Oct 2018

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech, a member of the Roche Group, today announced positive results from the Phase III IMpower130 study of Tecentriq (atezolizumab) plus chemotherapy (carboplatin and Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of people with previously untreated metastatic non-squamous non-small cell lung cancer.

22 Oct 2018

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.

22 Oct 2018

‘Contraception deserts’ likely to widen under new Trump administration policy

When Nikia Jackson needed to be screened for a sexually transmitted disease, she wanted a clinic that was reputable, quick and inexpensive.

28 Sep 2018

Ovarian cancer risk reduced among women taking modern combined oral contraceptive pills

According to a new study women of reproductive age who are using the modern oral contraceptive pills or patches and rings that contain a combination of estrogen and progesterone are at a reduced risk for ovarian cancer. The study was published in the recent issue of the British Medical Journal (BMJ).

27 Sep 2018

Beauty products contain mixed chemicals that may harm women's hormones

As we go about our daily lives, we are exposed to many different chemicals that could have negative effects on our hormones.

14 Sep 2018

Good skin care practices can help teens to battle stubborn acne

Being a teenager can be tough. Teens must manage high school and the pressures of adolescence while at the same time battling stubborn acne.

6 Sep 2018

Medicaid expansion may fill gap in reproductive health care access, study finds

Medicaid expansion may fill a significant gap in reproductive health care access, especially among young and low-income women, a new Michigan Medicine study finds.

31 Aug 2018

Tips to know your ovarian cancer risk and symptoms

Ovarian cancer is the fifth leading cause of death in American women, according to the American Cancer Society, and accounts for more deaths than any other cancer of the female reproductive system. And according to the National Cancer Institute, approximately 22,240 women will be diagnosed with the disease in 2018; 14,070 will die from it.

28 Aug 2018

Biorhythms and birth control: FDA stirs debate by approving ‘natural’ app

The Food and Drug Administration took a "big tent" approach earlier this month when it approved two new forms of birth control that prevent pregnancy in very different ways.

21 Aug 2018